Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): Roche - final scrutiny letter
|
Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): Roche - final scrutiny letter
16 May 2011 (12.37 Kb 3 sec) |
This page was last updated: 13 May 2011